Nobel Prize in Medicine for the COVID-19 vaccine?
Scientists behind the COVID-19 vaccine may be in the running to win the Nobel Prize in Medicine, even though the epidemic is not over.
Some scientists say it’s just a matter of time: if the work done to develop the vaccine is not recognized when this year’s award is announced on Monday, it could win the award in the years to come. Will
More than 4.7 million people have died from COVID-19 since the first case of the novel coronavirus was registered in 2019, and many countries are still living under strict restrictions to prevent its spread.
But the COVID-19 vaccine has helped some wealthy states return to normal, while others are still receiving large doses of the vaccine.
Among other scientists seen as potential winners of the Nobel Prize in Medicine are Hungarian-born Catalin Kreiko and American Drew Weissman for their work on the messenger ribonucleic acid (MRNA) vaccine. Are famous from
The mRNA vaccine, developed by Moderina and Pfizer and its German partner Biotech, has revolutionized the fight against the virus. They are fast and very efficient.
“The technique will sooner or later be rewarded,” said Ali Mirazmi, a professor of laboratory medicine at the Karolinska Institutet in Sweden. “The question is, when?”
Conventional vaccines, which introduce a weakened or dead virus to stimulate the body’s immune system, can take a decade or more to develop. Modrina’s mRNA vaccine went from human sequencing to the first human injection in 63 days.
The mRNA carries messages from the body’s DNA to its cells, telling them that it makes proteins necessary for vital functions, such as coordinating biological processes, including digestion or fighting disease.
The new vaccines use laboratory-made mRNA to instruct cells to make spike proteins from the corona virus, which stimulates the immune system to act without replicating it like a real virus.
MRNA was discovered in 1961, but it took scientists decades to fix the mRNA technique with problems such as instability and inflammatory conditions.
The developers now hope that in the future it can be used to treat both cancer and HIV (human immunodeficiency virus).
Adam Frederick Sander Bertelson, an associate professor at the University of Copenhagen, said: ۔ ” Chief Scientific Officer of the vaccine company Adaptvac
“It has actually saved thousands of lives because of its speed and efficiency, so I can well support that.” Carico, 66, founded the MRNA vaccine and Weissman, 62, is a longtime partner.
“They are the brains behind the discovery of mRNA,” Mirazmi said. He added: “They may be very young. The (Noble) Committee usually waits until the recipients are in their 80s.”
Carico, along with colleagues at the University of Pennsylvania, made a breakthrough by figuring out how to deliver mRNA without kicking the immune system into overdrive.
The Nobel Prize was founded by Dynamite inventor Alfred Nobel and is awarded for achievements in medicine, chemistry, literature, peace and physics. This year’s winners are announced between October 4 and 11, beginning with Madison.